实用肝脏病杂志2017，Vol.20Issue(2)：171-174,4.DOI:10.3969/j.issn.1672-5069.2017.02.011
裸金属支架与PTFE-覆膜支架行TIPSS治疗门静脉高压症患者临床疗效对比研究
Comparison of technical and clinical efficacy of bare metal stent and PTFE-stentgraft of TIPSS in the treatment of patients with portal hypertension
周筱燕 1高娜 1周岩芬1
作者信息
- 1. 710003 西安市 陕西省中医医院心血管病介入科
- 折叠
摘要
Abstract
Objective To compare the technical and clinical efficacy of bare metal stent (BMS) and polytetrafluoroethylene (PTFE)-stentgraft of transjugular intrahepatic portosystemic shunt (TIPSS) in treatment of patients with portal hypertension (PH). Methods 163 patients (56 ±12 ys,32.9 % females) with PH receiving TIPSS were recuited in this study,and 80 patients received BMS and 83 received PTFE-stentgraft. Results The technical success rate was 97.5% due to four unsuccessful interventions. The portosystemic gradient decreased from (16.1 ±4.8) mmHg to (5.1 ±2.1) mmHg in the successful series. There was no significant differences as respect to technical success rate and portosystemic gradient decrease between the two groups;Kaplan-Meier analysis yielded significant differences in primary patency after 14 days,6 months and 2 years thereafter in favour of the stentgraft;Both groups showed good clinical results without significant difference in 1-year survival and hepatic encephalopathy occurrence;Costs to establish TIPSS and maintain 2-year follow-up for constant patency were 66570 yuan in BMS group and 70455 yuan in PTFE-stentgraft. Conclusion TIPSS is a safe and effective procedure to manage portal hypertension. Both BMS stent and PTFE-stentgraft enable good technical and clinical outcomes with low complication rate,while the primary patency rate is clearly in favour of the stentgraft with a relative high costs.关键词
门静脉高压症/经颈静脉肝内门腔静脉支架分流术/裸金属支架/PTFE-覆膜支架Key words
Portal hypertension/Transjugular intrahepatic portosystemic shunt/Bare metal stent/polytetrafluoroethylene-stentgraft引用本文复制引用
周筱燕,高娜,周岩芬..裸金属支架与PTFE-覆膜支架行TIPSS治疗门静脉高压症患者临床疗效对比研究[J].实用肝脏病杂志,2017,20(2):171-174,4.
